I tumorer bidrager aktivering af KRAS via EGFR til EGFR- medieret øget celleproliferation, celleoverlevelse og produktion af pro- angiogene faktorer.
In tumours, activation of KRAS by EGFR contributes to EGFR-mediated increased proliferation, survival and the production of pro-angiogenic factors.